HOTH News and Press, Hoth Therapeutics Inc. From 10/12/21

Hoth Therapeutics Receives Approval to Commence Cohort 2 in Clinical Trial of BioLexa for the Treatment of Atopic Dermatitis Patients PR Newswire NEW YORK , Oct. 12, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical compan...

Detroit, Michigan--(Newsfile Corp. - September 22, 2021) - Hoth Therapeutics, Inc. (NASDAQ: HOTH) will be presenting at the Benzinga Healthcare Small Cap Conference taking place on September 29-30, 2021. We invite our shareholders and all interested parties to explore healthcare small cap ...

Hoth Therapeutics Submits to Ethics Committee for Approval to Initiate Patient Cohort 2 in BioLexa Clinical Trial Marks final step toward initiating Cohort 2 of patients with mild-to-moderate eczema Based on the recommendations of the Safety Review Committee Hoth has submitt...

Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa No serious adverse events and no drug-related treatment-emergent adverse events observed. BioLexa is a first in class treatment for Eczema PR Newswire N...

3 Penny Stocks to Watch as SPRT Stock Climbs Higher Penny stocks are climbing higher again as SPRT stock shows the meteoric potential of former small-caps. For those unfamiliar, Support.com Inc. ( NASDAQ: SPRT ) is a provider of customer support services. And while this alone is a p...

Hoth Therapeutics' mRNA 'Frameshifting' Therapy HT-KIT for Mast Cell Cancers Reduces Size, Spread - Research Published in Molecular Therapy Targeting KIT by frameshifting mRNA transcripts as a therapeutic strategy for aggressive mast cell neoplasm PR Newswire NEW Y...

CohBar (NASDAQ:CWBR) +62% on Q2 earnings Good Times Restaurant (NASDAQ:GTIM) +32% on Q3 earnings Upstart Holdings (NASDAQ:UPST) +22% on Q2 earnings Mogo (NASDAQ:MOGO) +20% on Q2 earnings fuboTV (NYSE:FUBO) +16% on Q2 earnings Lantern Pharma (N...

Hoth Therapeutics (NASDAQ:HOTH) announces that it has initiated a preclinical study of HT-ALZ for the treatment of Alzheimer's disease. The goal of the study is to determine the effects of HT-ALZ on behavioral and pathological markers of Alzheimer's disease and to determine if HT-ALZ can impr...

Hoth Therapeutics Initiates Preclinical Study of HT-ALZ for Alzheimer's Disease PR Newswire NEW YORK , Aug. 2, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a patient-focused biopharmaceutical company , announced today that it has ...

Hoth Therapeutics ([[HOTH]]) announces positive confirmatory results from in vivo model of HT-003 assets as potential treatment against acne.The model showed that HT-003 reduces the expression of toll-like receptor 2 ((TLR2)), one of the most critical pathways for acne pathophysiology.Th...